A linear programming assessment of the profit from strategies to reduce the prevalence of Staphylococcus aureus mastitis
We used a linear programming model to estimate the financial returns to a Staphylococcus aureus testing and control program over a 1-year period for a 100-cow herd, with a 8636-kg rolling-herd average. Six tests, which vary in sensitivity from 0.80 to 0.98 and specificity of 0.99, were examined in s...
Gespeichert in:
| Veröffentlicht in: | Preventive veterinary medicine 1998, Vol.33 (1), p.183-193 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 193 |
|---|---|
| container_issue | 1 |
| container_start_page | 183 |
| container_title | Preventive veterinary medicine |
| container_volume | 33 |
| creator | Zepeda, Lyctia Buelow, Kenneth L Nordlund, Kenneth V Thomas, chester B Collins, Michael T Goodger, William J |
| description | We used a linear programming model to estimate the financial returns to a
Staphylococcus aureus testing and control program over a 1-year period for a 100-cow herd, with a 8636-kg rolling-herd average. Six tests, which vary in sensitivity from 0.80 to 0.98 and specificity of 0.99, were examined in simulated herds with 10, 20 and 30% prevalence of
S. aureus infection. Sensitivity of these results to a range of assumptions regarding rolling-herd average, milk price, somatic cell-count premium, and cost and cure rate of dry treatment were examined to determine the profits from the program. The profits of a control program are most dependent upon prevalence, cell-count premium, and cost of dry treatment. In our simulation for a 100-cow herd, a testing and control program appears to cost less than US$10 per cow per year, and pays for itself within 1 yr, except under the lowest prevalence and most-adverse conditions (low yield, high cost of dry treatment, or low SCC premium). |
| doi_str_mv | 10.1016/S0167-5877(97)00054-8 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79724287</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0167587797000548</els_id><sourcerecordid>79724287</sourcerecordid><originalsourceid>FETCH-LOGICAL-c382t-3668007a0be735aa52cd775852b3bc194b510ee1d55e933fc577583381aecd633</originalsourceid><addsrcrecordid>eNqFkMFu3CAQhlHUKN1u8wiROFXtwQ2YxcCpiqImjbRqD2nPCOPxhso2WwZHydsXZ1fpsRdG6PuHGT5CLjj7zBlvLu_LoSqplfpo1CfGmNxU-oSsuFai4oo3b8jqNfKWvEP8XUJNo-UZOTOSMa7Eijxd0SFM4BLdp7hLbhzDtKMOERBHmDKNPc0PsNA-ZNqnOFLMyWXYBUCaI03QzR6OIXh0A0zlWtrus9s_PA_RR-9npG5OUMroMIcc8D057d2AcH6sa_Lr5uvP62_V9sft3fXVtvJC17kSZWHGlGMtKCGdk7XvlJJa1q1oPTebVnIGwDspwQjRe7lQITR34LtGiDX5cHi3_ODPDJjtGNDDMLgJ4oxWGVVv6uJsTeQh6FNETNDbfQqjS8-WM7sYty_G7aLTGmVfjFtd-i6OA-Z2hO6166j4H-9dtG6XAtrvW26MXjA3hX85cCgWHgMkiz4sDruQwGfbxfCfDf4Cw5CbJA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79724287</pqid></control><display><type>article</type><title>A linear programming assessment of the profit from strategies to reduce the prevalence of Staphylococcus aureus mastitis</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Zepeda, Lyctia ; Buelow, Kenneth L ; Nordlund, Kenneth V ; Thomas, chester B ; Collins, Michael T ; Goodger, William J</creator><creatorcontrib>Zepeda, Lyctia ; Buelow, Kenneth L ; Nordlund, Kenneth V ; Thomas, chester B ; Collins, Michael T ; Goodger, William J</creatorcontrib><description>We used a linear programming model to estimate the financial returns to a
Staphylococcus aureus testing and control program over a 1-year period for a 100-cow herd, with a 8636-kg rolling-herd average. Six tests, which vary in sensitivity from 0.80 to 0.98 and specificity of 0.99, were examined in simulated herds with 10, 20 and 30% prevalence of
S. aureus infection. Sensitivity of these results to a range of assumptions regarding rolling-herd average, milk price, somatic cell-count premium, and cost and cure rate of dry treatment were examined to determine the profits from the program. The profits of a control program are most dependent upon prevalence, cell-count premium, and cost of dry treatment. In our simulation for a 100-cow herd, a testing and control program appears to cost less than US$10 per cow per year, and pays for itself within 1 yr, except under the lowest prevalence and most-adverse conditions (low yield, high cost of dry treatment, or low SCC premium).</description><identifier>ISSN: 0167-5877</identifier><identifier>EISSN: 1873-1716</identifier><identifier>DOI: 10.1016/S0167-5877(97)00054-8</identifier><identifier>PMID: 9500173</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Animals ; BENEFICE ; BOVINE MASTITIS ; Cattle ; Cell Count - veterinary ; Control ; CONTROL DE ENFERMEDADES ; CONTROLE DE MALADIES ; Cost-Benefit Analysis ; COWS ; DISEASE CONTROL ; ECONOMIA ; ECONOMICS ; ECONOMIE ; ETATS UNIS ; EUA ; Female ; GANANCIAS ; Linear Models ; LINEAR PROGRAMMING ; MAMMITE BOVINE ; Mastitis ; MASTITIS BOVINA ; Mastitis, Bovine - economics ; Mastitis, Bovine - epidemiology ; Mastitis, Bovine - prevention & control ; Milk - cytology ; Milk - economics ; Milk - microbiology ; Modelling ; Models, Economic ; Prevalence ; PROFIT ; PROGRAMACION LINEAL ; PROGRAMMATION LINEAIRE ; Staphylococcal Infections - economics ; Staphylococcal Infections - prevention & control ; Staphylococcal Infections - veterinary ; STAPHYLOCOCCUS AUREUS ; Staphylococcus aureus - isolation & purification ; Staphylococcus aureus - physiology ; Strategies ; USA ; VACA ; VACHE</subject><ispartof>Preventive veterinary medicine, 1998, Vol.33 (1), p.183-193</ispartof><rights>1998</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c382t-3668007a0be735aa52cd775852b3bc194b510ee1d55e933fc577583381aecd633</citedby><cites>FETCH-LOGICAL-c382t-3668007a0be735aa52cd775852b3bc194b510ee1d55e933fc577583381aecd633</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0167-5877(97)00054-8$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,4024,27923,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9500173$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zepeda, Lyctia</creatorcontrib><creatorcontrib>Buelow, Kenneth L</creatorcontrib><creatorcontrib>Nordlund, Kenneth V</creatorcontrib><creatorcontrib>Thomas, chester B</creatorcontrib><creatorcontrib>Collins, Michael T</creatorcontrib><creatorcontrib>Goodger, William J</creatorcontrib><title>A linear programming assessment of the profit from strategies to reduce the prevalence of Staphylococcus aureus mastitis</title><title>Preventive veterinary medicine</title><addtitle>Prev Vet Med</addtitle><description>We used a linear programming model to estimate the financial returns to a
Staphylococcus aureus testing and control program over a 1-year period for a 100-cow herd, with a 8636-kg rolling-herd average. Six tests, which vary in sensitivity from 0.80 to 0.98 and specificity of 0.99, were examined in simulated herds with 10, 20 and 30% prevalence of
S. aureus infection. Sensitivity of these results to a range of assumptions regarding rolling-herd average, milk price, somatic cell-count premium, and cost and cure rate of dry treatment were examined to determine the profits from the program. The profits of a control program are most dependent upon prevalence, cell-count premium, and cost of dry treatment. In our simulation for a 100-cow herd, a testing and control program appears to cost less than US$10 per cow per year, and pays for itself within 1 yr, except under the lowest prevalence and most-adverse conditions (low yield, high cost of dry treatment, or low SCC premium).</description><subject>Animals</subject><subject>BENEFICE</subject><subject>BOVINE MASTITIS</subject><subject>Cattle</subject><subject>Cell Count - veterinary</subject><subject>Control</subject><subject>CONTROL DE ENFERMEDADES</subject><subject>CONTROLE DE MALADIES</subject><subject>Cost-Benefit Analysis</subject><subject>COWS</subject><subject>DISEASE CONTROL</subject><subject>ECONOMIA</subject><subject>ECONOMICS</subject><subject>ECONOMIE</subject><subject>ETATS UNIS</subject><subject>EUA</subject><subject>Female</subject><subject>GANANCIAS</subject><subject>Linear Models</subject><subject>LINEAR PROGRAMMING</subject><subject>MAMMITE BOVINE</subject><subject>Mastitis</subject><subject>MASTITIS BOVINA</subject><subject>Mastitis, Bovine - economics</subject><subject>Mastitis, Bovine - epidemiology</subject><subject>Mastitis, Bovine - prevention & control</subject><subject>Milk - cytology</subject><subject>Milk - economics</subject><subject>Milk - microbiology</subject><subject>Modelling</subject><subject>Models, Economic</subject><subject>Prevalence</subject><subject>PROFIT</subject><subject>PROGRAMACION LINEAL</subject><subject>PROGRAMMATION LINEAIRE</subject><subject>Staphylococcal Infections - economics</subject><subject>Staphylococcal Infections - prevention & control</subject><subject>Staphylococcal Infections - veterinary</subject><subject>STAPHYLOCOCCUS AUREUS</subject><subject>Staphylococcus aureus - isolation & purification</subject><subject>Staphylococcus aureus - physiology</subject><subject>Strategies</subject><subject>USA</subject><subject>VACA</subject><subject>VACHE</subject><issn>0167-5877</issn><issn>1873-1716</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkMFu3CAQhlHUKN1u8wiROFXtwQ2YxcCpiqImjbRqD2nPCOPxhso2WwZHydsXZ1fpsRdG6PuHGT5CLjj7zBlvLu_LoSqplfpo1CfGmNxU-oSsuFai4oo3b8jqNfKWvEP8XUJNo-UZOTOSMa7Eijxd0SFM4BLdp7hLbhzDtKMOERBHmDKNPc0PsNA-ZNqnOFLMyWXYBUCaI03QzR6OIXh0A0zlWtrus9s_PA_RR-9npG5OUMroMIcc8D057d2AcH6sa_Lr5uvP62_V9sft3fXVtvJC17kSZWHGlGMtKCGdk7XvlJJa1q1oPTebVnIGwDspwQjRe7lQITR34LtGiDX5cHi3_ODPDJjtGNDDMLgJ4oxWGVVv6uJsTeQh6FNETNDbfQqjS8-WM7sYty_G7aLTGmVfjFtd-i6OA-Z2hO6166j4H-9dtG6XAtrvW26MXjA3hX85cCgWHgMkiz4sDruQwGfbxfCfDf4Cw5CbJA</recordid><startdate>1998</startdate><enddate>1998</enddate><creator>Zepeda, Lyctia</creator><creator>Buelow, Kenneth L</creator><creator>Nordlund, Kenneth V</creator><creator>Thomas, chester B</creator><creator>Collins, Michael T</creator><creator>Goodger, William J</creator><general>Elsevier B.V</general><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>1998</creationdate><title>A linear programming assessment of the profit from strategies to reduce the prevalence of Staphylococcus aureus mastitis</title><author>Zepeda, Lyctia ; Buelow, Kenneth L ; Nordlund, Kenneth V ; Thomas, chester B ; Collins, Michael T ; Goodger, William J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c382t-3668007a0be735aa52cd775852b3bc194b510ee1d55e933fc577583381aecd633</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Animals</topic><topic>BENEFICE</topic><topic>BOVINE MASTITIS</topic><topic>Cattle</topic><topic>Cell Count - veterinary</topic><topic>Control</topic><topic>CONTROL DE ENFERMEDADES</topic><topic>CONTROLE DE MALADIES</topic><topic>Cost-Benefit Analysis</topic><topic>COWS</topic><topic>DISEASE CONTROL</topic><topic>ECONOMIA</topic><topic>ECONOMICS</topic><topic>ECONOMIE</topic><topic>ETATS UNIS</topic><topic>EUA</topic><topic>Female</topic><topic>GANANCIAS</topic><topic>Linear Models</topic><topic>LINEAR PROGRAMMING</topic><topic>MAMMITE BOVINE</topic><topic>Mastitis</topic><topic>MASTITIS BOVINA</topic><topic>Mastitis, Bovine - economics</topic><topic>Mastitis, Bovine - epidemiology</topic><topic>Mastitis, Bovine - prevention & control</topic><topic>Milk - cytology</topic><topic>Milk - economics</topic><topic>Milk - microbiology</topic><topic>Modelling</topic><topic>Models, Economic</topic><topic>Prevalence</topic><topic>PROFIT</topic><topic>PROGRAMACION LINEAL</topic><topic>PROGRAMMATION LINEAIRE</topic><topic>Staphylococcal Infections - economics</topic><topic>Staphylococcal Infections - prevention & control</topic><topic>Staphylococcal Infections - veterinary</topic><topic>STAPHYLOCOCCUS AUREUS</topic><topic>Staphylococcus aureus - isolation & purification</topic><topic>Staphylococcus aureus - physiology</topic><topic>Strategies</topic><topic>USA</topic><topic>VACA</topic><topic>VACHE</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zepeda, Lyctia</creatorcontrib><creatorcontrib>Buelow, Kenneth L</creatorcontrib><creatorcontrib>Nordlund, Kenneth V</creatorcontrib><creatorcontrib>Thomas, chester B</creatorcontrib><creatorcontrib>Collins, Michael T</creatorcontrib><creatorcontrib>Goodger, William J</creatorcontrib><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Preventive veterinary medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zepeda, Lyctia</au><au>Buelow, Kenneth L</au><au>Nordlund, Kenneth V</au><au>Thomas, chester B</au><au>Collins, Michael T</au><au>Goodger, William J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A linear programming assessment of the profit from strategies to reduce the prevalence of Staphylococcus aureus mastitis</atitle><jtitle>Preventive veterinary medicine</jtitle><addtitle>Prev Vet Med</addtitle><date>1998</date><risdate>1998</risdate><volume>33</volume><issue>1</issue><spage>183</spage><epage>193</epage><pages>183-193</pages><issn>0167-5877</issn><eissn>1873-1716</eissn><abstract>We used a linear programming model to estimate the financial returns to a
Staphylococcus aureus testing and control program over a 1-year period for a 100-cow herd, with a 8636-kg rolling-herd average. Six tests, which vary in sensitivity from 0.80 to 0.98 and specificity of 0.99, were examined in simulated herds with 10, 20 and 30% prevalence of
S. aureus infection. Sensitivity of these results to a range of assumptions regarding rolling-herd average, milk price, somatic cell-count premium, and cost and cure rate of dry treatment were examined to determine the profits from the program. The profits of a control program are most dependent upon prevalence, cell-count premium, and cost of dry treatment. In our simulation for a 100-cow herd, a testing and control program appears to cost less than US$10 per cow per year, and pays for itself within 1 yr, except under the lowest prevalence and most-adverse conditions (low yield, high cost of dry treatment, or low SCC premium).</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>9500173</pmid><doi>10.1016/S0167-5877(97)00054-8</doi><tpages>11</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0167-5877 |
| ispartof | Preventive veterinary medicine, 1998, Vol.33 (1), p.183-193 |
| issn | 0167-5877 1873-1716 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_79724287 |
| source | MEDLINE; Elsevier ScienceDirect Journals Complete |
| subjects | Animals BENEFICE BOVINE MASTITIS Cattle Cell Count - veterinary Control CONTROL DE ENFERMEDADES CONTROLE DE MALADIES Cost-Benefit Analysis COWS DISEASE CONTROL ECONOMIA ECONOMICS ECONOMIE ETATS UNIS EUA Female GANANCIAS Linear Models LINEAR PROGRAMMING MAMMITE BOVINE Mastitis MASTITIS BOVINA Mastitis, Bovine - economics Mastitis, Bovine - epidemiology Mastitis, Bovine - prevention & control Milk - cytology Milk - economics Milk - microbiology Modelling Models, Economic Prevalence PROFIT PROGRAMACION LINEAL PROGRAMMATION LINEAIRE Staphylococcal Infections - economics Staphylococcal Infections - prevention & control Staphylococcal Infections - veterinary STAPHYLOCOCCUS AUREUS Staphylococcus aureus - isolation & purification Staphylococcus aureus - physiology Strategies USA VACA VACHE |
| title | A linear programming assessment of the profit from strategies to reduce the prevalence of Staphylococcus aureus mastitis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T10%3A22%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20linear%20programming%20assessment%20of%20the%20profit%20from%20strategies%20to%20reduce%20the%20prevalence%20of%20Staphylococcus%20aureus%20mastitis&rft.jtitle=Preventive%20veterinary%20medicine&rft.au=Zepeda,%20Lyctia&rft.date=1998&rft.volume=33&rft.issue=1&rft.spage=183&rft.epage=193&rft.pages=183-193&rft.issn=0167-5877&rft.eissn=1873-1716&rft_id=info:doi/10.1016/S0167-5877(97)00054-8&rft_dat=%3Cproquest_cross%3E79724287%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=79724287&rft_id=info:pmid/9500173&rft_els_id=S0167587797000548&rfr_iscdi=true |